RECENT PROGRESS IN CALOPHYLLUM COUMARINS AS POTENT ANTI-HIV AGENTS - Medicinal Chemistry of Bioactive Natural Products - page 354

41. Sarawak Medichem Pharmaceuticals. A phase 1B dose-range study to evaluate the
safety, pharmacokinetics, and effects of ( þ )-calanolide A on surrogate marker in HIV-
positive patients with no previous antiretroviral therapy. Protocol FDA 297A, 1998.
42. Chenera, B.; West, M. L.; Finkelstein, J. A.; Dreyer, G. B. Total synthesis of ( )-
calanolide A, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. J. Org. Chem.,
1993, 58: 5605.
43. Kucherenko, A.; Flavin, M. T.; Boulanger, W. A.; Khilevich, A.; Shone, R. L.; Rizzo, J. D.;
Sheinkmann, A. K.; Xu, Z. Q. Novel approach for synthesis of ( )-calanolide A and its
anti-HIV activity. Tetrahedron Lett., 1995, 36(31): 5475-5478.
44. Zhou, C. M.; Wang, L.; Zhang, M. L.; Zhao, Z. Z.; Zhang, X. Q.; Chen, X. H.; Chen, H. S.
Total synthesis of ( )-calanolide A and its anti-HIV activity. Chin. Chem. Lett., 1998,9:
433-434.
45. Zhou, C. M.; Wang, L.; Zhang, M. L.; Zhao, Z. Z.; Zhang, X. Q.; Chen, X. H.; Chen, H.
S. Synthesis and anti-HIV activity of ( )-calanolide A and its analogues. Acta
Pharmaceutica Sinica, 1999, 34: 673-678.
46. Gao, Q.; Wang, L.; Liang, X. T. Total synthesis of ( )-inophyllum B. Chin. Chem. Lett.,
2002, 13: 714-716.
47. Gao, Q.; Wang, L.; Liang, X. T. Total synthesis of ( )-cordatolide A and its anti-HIV
acitivity. Chin. Chem. Lett., 1999, 10: 653-656.
48. Palmer, C. J.; Josephs, J. L. Synthesis of the Calophyllum coumarins. Tetrahedron Lett.,
1994, 35: 5363-5366.
49. Deshpande, P. P.; Tagliaferri, F.; Victory, S. F.; Yan, S.; Baker, D. C. Synthesis of
optically active calanolide A and B. J. Org. Chem., 1995, 60(10): 2964-2965.
50. Deshpande, P. P.; Baker, D. C. A simple approach to the synthesis of the chiral
substituted chroman ring of calophyllum coumarins. Synthesis, 1995, 630-632.
51. Sekino, E.; Kumamoto, T.; Tanaka, T.; Ikeda, T.; Ishikawa, T. Concise synthesis of anti-
HIV-1 active ( þ )-inophyllum B and ( þ )-calanolide A by application of ( )-quinine-
catalyzed intramolecular oxo-Michael addition. J. Org. Chem., 2004, 69: 2760-2769.
52. Ishikawa, T.; Oku, Y.; Tanaka, T.; Kumanoto, T. An approach to anti-HIV-1 active
calophyllum coumarin synthesis: An enantioselective construction of 2,3-dimethyl-4-
chromanone ring by quinine-assisted intramolecular Michael-type addition. Tetrahedron
Lett., 1999, 40: 3777-3780.
53. Tanaka, T.; Kumanoto, T.; Ishikawa, T. Solvent effects on stereoselectivity in 2,3-
dimethyl-4- chromanone cyclization by quinine-catalyzed asymmetric intromolecular
oxo-Michael addition. Tetrahedron-Asymmetry, 2000, 11: 4633-4637.
54. Tanaka, T.; Kumanoto, T.; Ishikawa, T. Enantioselective total synthesis of anti HIV-1
active ( þ )-calanolide

A through a quinine-catalyzed asymmetric intromolecular

oxo-Michael addition. Tetrahedron Lett., 2000, 41: 10229-10232.
55. Trost, B. M.; Toste, F. D. A catalytic enantioselective approach to chromans and
chromanols. A total synthesis of ( )-calanolide A and B and the Vitamin E nucleus.
J. Am. Chem. Soc., 1998, 120: 9074-9075.
56. Khilevich, A.; Mar, A.; Flavin, M. T.; Rizzo, J. D.; Lin, L.; Dzekhtser, S.; Brankovic, D.;
Zhang, H. P.; Chen, W.; Liao, S. Y. Synthesis of ( þ )-calanolide, A.: An anti-HIV agent,
via enzyme-catalyzed resolution of the aldol products. Tetrahedron-Asymmetry, 1996,7:
3315-3326.